Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sumitomo Chemical India Limited (SUMICHEM.NS)
Mumbai, IN
Sumitomo Chemical India Limited (SCIL) specializes in the global production and distribution of a diverse array of chemical products. Its core business encompasses the manufacture and sale of insecticides for household and public health use, agricultural crop protection agents, and animal nutritional supplements, catering to both Indian and international markets. The company's operations are structured into two primary segments: Agro Chemicals and other diversified offerings. SCIL's extensive product line includes a variety of crop protection solutions, such as insecticides, herbicides, fungicides, and miticides. Additionally, it provides plant growth regulators, animal nutrition products, pest control items like fumigants and rodenticides, weedicides, and various biological products. Established in 2000, Sumitomo Chemical India Limited is headquartered in Mumbai, India, and operates as a subsidiary of Sumitomo Chemical Company Limited.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.32% | +4.66% | +11.40% | +23.52% | +8.00% | +5.20% | -1.53% | +23.47% | +53.98% | +146.89% | +146.89% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Agricultural Inputs: +9.5%+2.9% Q1'26: +0.6% (vs Q1'25)
-
EPS growth Agricultural Inputs: +23.0%+7.4% Q1'26: +11.5% (vs Q1'25)
-
FCF margin FCF growth · Agricultural Inputs: +27.6%+11.3% Q1'26: +61.4% (vs Q1'25)
-
EBIT margin Agricultural Inputs: +9.7%+18.7% ★ Q1'26: +17.1% (vs Q1'25)
-
ROIC Agricultural Inputs: +7.4%+18.4% ★ Q1'26: +14.4% (vs Q1'25)
-
Share dilution Agricultural Inputs: +0.0%0.0% ★ Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Agricultural Inputs: 0.03×0.09× ★ Q1'26: 0.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 7 Rev. Ana. 6 EPS Ana. |
Mar 2027 7 Rev. Ana. 7 EPS Ana. |
Mar 2028 7 Rev. Ana. 7 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
24.25B
est: 23.94B (+1.3%)
|
26.45B
est: 26.41B (+0.1%)
|
30.61B
est: 30.65B (-0.1%)
|
35.11B
est: 35.11B (0.0%)
|
28.44B
est: 29.59B (-3.9%)
|
31.49B
est: 32.46B (-3.0%)
|
32.72B
31.84B – 34.27B
+0.8% YoY
|
35.99B
34.81B – 38.30B
+10.0% YoY
|
40.33B
38.86B – 42.45B
+12.0% YoY
|
| EBITDA |
3.25B
est: 4.34B (-25.2%)
|
4.74B
est: 3.38B (+40.1%)
|
5.82B
est: 3.98B (+46.4%)
|
6.47B
est: 4.72B (+37.0%)
|
4.53B
est: 5.37B (-15.5%)
|
6.10B
est: 5.97B (+2.1%)
|
5.93B
5.77B – 6.21B
-0.6% YoY
|
6.53B
6.31B – 6.95B
+10.0% YoY
|
7.31B
7.05B – 7.70B
+12.0% YoY
|
| EBIT |
2.97B
est: 4.07B (-27.0%)
|
4.44B
est: 3.03B (+46.2%)
|
5.57B
est: 3.57B (+56.1%)
|
6.15B
est: 4.23B (+45.2%)
|
4.12B
est: 5.03B (-18.0%)
|
5.66B
est: 5.59B (+1.2%)
|
5.56B
5.41B – 5.82B
-0.6% YoY
|
6.12B
5.91B – 6.51B
+10.0% YoY
|
6.85B
6.60B – 7.21B
+12.0% YoY
|
| Net Income |
2.05B
est: 2.25B (-8.9%)
|
3.45B
est: 2.29B (+50.6%)
|
4.24B
est: 2.70B (+57.1%)
|
5.02B
est: 3.20B (+56.9%)
|
3.70B
est: 4.35B (-15.0%)
|
5.05B
est: 5.57B (-9.3%)
|
5.63B
5.53B – 5.74B
+1.1% YoY
|
6.40B
5.87B – 6.61B
+13.6% YoY
|
7.43B
6.85B – 7.91B
+16.1% YoY
|
| SGA |
2.27B
est: 2.14B (+5.9%)
|
2.32B
est: 4.68B (-50.4%)
|
2.45B
est: 5.50B (-55.5%)
|
2.69B
est: 6.53B (-58.8%)
|
2.90B
est: 2.64B (+9.8%)
|
3.16B
est: 2.94B (+7.5%)
|
2.92B
2.85B – 3.06B
-0.6% YoY
|
3.22B
3.11B – 3.42B
+10.0% YoY
|
3.60B
3.47B – 3.79B
+12.0% YoY
|
| EPS |
4.10
est: 4.50 (-8.9%)
|
6.92
est: 7.03 (-1.5%)
|
8.49
est: 8.78 (-3.3%)
|
10.06
est: 10.21 (-1.5%)
|
7.40
est: 8.70 (-14.9%)
|
10.13
est: 10.92 (-7.2%)
|
11.41
11.07 – 11.50
+4.5% YoY
|
12.65
11.76 – 13.24
+10.8% YoY
|
14.85
13.73 – 15.85
+17.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | C | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Chetan Shantilal Shah | MD & Executive Director | 89M | male |
| Sushil Champaklal Marfatia | Executive Director | 30M | male |
| Suresh Ramachandran | Deputy MD & Whole Time Director | 22M | male |
| Kalpesh Patel | Vice President of Sales & Marketing | — | — |
| Kunal Suresh Mittal | Senior Vice President of Planning & Coordination Office | — | male |
| Maddika Nagarjuna Reddy | Vice President of Sales & Marketing | — | male |
| Pankaj Garara | Vice President of Sales & Marketing | — | — |
| Anil S. Nawal | Chief Financial Officer | — | male |
| Yoshihisa Inoue | Senior Vice President of Manufacturing | — | male |
| Deepika Trivedi | Company Secretary & Compliance Officer | — | female |
| Gaganpreet Singh | Vice President of Sales & Marketing | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for SUMICHEM.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
